RAPHAEL PHARMACEUTICAL INC (RAPH:OTCMKTS)
$0 None (None%)
Analysed RAPHAEL PHARMACEUTICAL INC (RAPH:OTCMKTS) News Sources
Raphael Pharmaceutical Announces Filing of Provisional Patent Application for the Treatment of Neutrophil-Dominant Autoimmune Diseases, Including Rheumatoid Arthritis (RA)
17-11-2025
yahoo.com
What is the current price of RAPHAEL PHARMACEUTICAL INC (RAPH:OTCMKTS)?
The current price of RAPHAEL PHARMACEUTICAL INC (RAPH:OTCMKTS) is $0.
RAPHAEL PHARMACEUTICAL INC (RAPH:OTCMKTS) absolute price change since previous trading day?
The absolute price change of RAPHAEL PHARMACEUTICAL INC (RAPH:OTCMKTS) since the previous trading day is $None.
RAPHAEL PHARMACEUTICAL INC (RAPH:OTCMKTS) percentage price change since previous trading day?
The percentage price change of RAPHAEL PHARMACEUTICAL INC (RAPH:OTCMKTS) since the previous trading day is None%.
What is the most recent average sentiment score for RAPHAEL PHARMACEUTICAL INC (RAPH:OTCMKTS)?
The most recent average sentiment score for RAPHAEL PHARMACEUTICAL INC (RAPH:OTCMKTS) is 81 out of 100.
What is the most recent average sentiment for RAPHAEL PHARMACEUTICAL INC (RAPH:OTCMKTS)?
The most recent sentiment for RAPHAEL PHARMACEUTICAL INC (RAPH:OTCMKTS) is .
SEC-8K** Filing Available For RAPHAEL PHARMACEUTICAL INC (RAPH:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.